Entropion Treatment Market Players:
- Alembic Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eli Lilly and Company
- Bausch & Lomb Incorporated
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Sanofi-aventis Groupe
- Abbott Laboratories
- Merck & Co., Inc.
- Siemens Healthcare GmbH
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of entropion treatment is assessed at USD 538.67 million.
The global entropion treatment market size was valued at over USD 507.6 million in 2025 and is expected to expand at a CAGR of around 6.8%, surpassing USD 980.02 million revenue by 2035.
North America entropion treatment market is anticipated to command a leading revenue share, fueled by the escalating incidence of age-related entropion and widespread dry eye conditions across the elderly population.
Key players in the market include Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited.
